The relationship between ovarian structure and serum insulin, insulin-like growth factor-I (IGF-I) and its binding protein (IGFBP-1 and IGFBP-3) levels in premature pubarche

Journal of Pediatric Endocrinology and Metabolism

Volumn 15, Issue 1, 2002, Pages 69-75

  Teixeira, Rosimere J ^a   Silva, Valéria C G ^a   Gazolla, Helena M ^a   Cunha, Sônia B ^a   Guimarães, Marília M ^a  

^a HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

Author keywords

IGF I; IGFBP 1; IGFBP 3; Insulin; Ovarian microcysts; Premature pubarche

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CORTICOTROPIN; GLUCOSE; INSULIN; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; STEROID HORMONE; TESTOSTERONE;

ADULTHOOD; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOTROPIN TEST; DIET RESTRICTION; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; HYPERANDROGENISM; HYPOTHESIS; INSULIN RESISTANCE; OVARY; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; PRECOCIOUS PUBERTY; PREDICTION; PROTEIN INTERACTION; PUBERTY; REGRESSION ANALYSIS; RISK ASSESSMENT; STRUCTURE ANALYSIS;

EID: 0036003814     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2002.15.1.69     Document Type: Article

References (38)

1. How possible is the prevention of polycystic ovary syndrome development in adolescent patients with early onset of hyperandrogenism?
2. Precocious pubarche in girls may be a marker of a polyendocrinopathy
3. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: Increased frequency of functional ovarian hyperandrogenism
4. Postpubertal assessment in girls with premature pubarche: Clinical, biochemical and echographic findings
5. Hormonal findings in African-American and Caribbean-Hispanic girls with premature adrenarche: Implications for polycystic ovarian syndrome
6. Premature adrenarche: Findings in prepubertal African-American and Caribbean-Hispanic girls
7. Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and polycystic ovary syndrome: From a complex constellation to a simple sequence of prenatal onset
8. Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages of puberty: Evidence from gonadotropin-releasing hormone agonist testing
9. Polycystic ovary syndrome/hyperandrogenic chronic anovulation
10. Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism
11. Hyperinsulinemia, dyslipidaemia and cardiovascular risk in girls with a history of premature pubarche
12. Ovaries in sexual precocity
13. Pelvic ultrasonography in premature pubarche
14. The relationship between ovarian structure and hyperandrogenism in premature pubarche
15. Nonclassic adrenal hyperplasia: Current concepts
16. Congenital adrenal hyperplasia
17. 5-steroid levels
18. Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome
19. Insulin infusion amplifies 17α-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: Apparent relative impairment of 17,20-lyase activity
20. Normative data for adrenal steroidogenesis in a healthy pediatric population: Age- and sex-related changes after adrenocorticotropin stimulation
21. Insulin resistance in obese and nonobese man
22. Ultra-sonografia pélvica em 140 meninas normais pré e pós-puberais
23. Puberty and polycystic ovarian syndrome: The insulin/insulin-like growth factor I hypothesis
24. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism
25. Editorial: Evidence that idiopathic functional ovarian hyperandrogenism is caused by dysregulation of adrenal steroidogenesis and that hyperinsulinemia may be involved
26. Decreased insulin sensitivity in prepubertal girls with premature adrenarche and acanthosis nigricans
27. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome
28. Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche
29. Editorial: Sex hormone-binding globulin: A marker for hyperinsulinemia and/or insulin resistance?
30. Lack of correlation between sex hormone binding globulin, adrenal and peripheral androgens in precocious adrenarche
31. Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome
32. The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome
33. The role of insulin sensitivity, IGF-1, IGFBP-1 and IGFBP-3 in the hyperandrogenism in Black and Hispanic girls with premature adrenarche
34. Serum insulin-like growth factor (IGF-I) and IGF binding protein-3 levels are increased in central precocious puberty: Effects of two different treatment regimes with gonadotropin-releasing hormone agonists, without with an antiandrogen (cyproterone acetate)
35. Insulin-like growth factor-1 and IGF binding protein-3 remain high after GnRH analogue therapy in girls with central precocious puberty
36. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: Implications for the onset of puberty
37. Serum insulin-like growth factor-I and IGF binding protein-3 levels in children with precocious puberty treated with gonadotropin-releasing hormone analog without or in combination with cyproterone acetate